Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Other financing activities (2016 - 2025)

Historic Other financing activities for United Therapeutics (UTHR) over the last 16 years, with Q2 2025 value amounting to $11.5 million.

  • United Therapeutics' Other financing activities changed N/A to $11.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 32592.59%. This contributed to the annual value of $2.7 million for FY2024, which is 0.0% changed from last year.
  • United Therapeutics' Other financing activities amounted to $11.5 million in Q2 2025.
  • In the past 5 years, United Therapeutics' Other financing activities ranged from a high of $11.5 million in Q2 2025 and a low of $2.7 million during Q1 2023
  • Over the past 4 years, United Therapeutics' median Other financing activities value was $5.1 million (recorded in 2022), while the average stood at $6.1 million.
  • Its Other financing activities has fluctuated over the past 5 years, first crashed by 6400.0% in 2023, then changed by 0.0% in 2024.
  • Over the past 4 years, United Therapeutics' Other financing activities (Quarter) stood at $7.5 million in 2022, then crashed by 64.0% to $2.7 million in 2023, then changed by 0.0% to $2.7 million in 2024, then skyrocketed by 325.93% to $11.5 million in 2025.
  • Its Other financing activities was $11.5 million in Q2 2025, compared to $2.7 million in Q1 2024 and $2.7 million in Q1 2023.